These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
438 related articles for article (PubMed ID: 35384317)
1. Incidence of active tuberculosis among people living with HIV receiving long-term antiretroviral therapy in high TB/HIV burden settings in Thailand: implication for tuberculosis preventive therapy. Suwanpimolkul G; Gatechompol S; Kawkitinarong K; Ueaphongsukkit T; Sophonphan J; Siriyakorn N; Jirajariyavej S; Khusuwan S; Panarat P; Wannalerdsakun S; Saetiew N; Chayangsu S; Wiwatrojanagul S; Noopetch P; Danpornprasert P; Mekviwattanawong S; Fujitnirun C; Lertpiriyasuwat C; Han WM; Kerr SJ; Ruxrungtham K; Avihingsanon A; J Int AIDS Soc; 2022 Apr; 25(4):e25900. PubMed ID: 35384317 [TBL] [Abstract][Full Text] [Related]
2. Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model. Gatechompol S; Sophonphan J; Ubolyam S; Avihingsanon A; van Leth F; Cobelens F; Kerr SJ BMC Infect Dis; 2022 Apr; 22(1):346. PubMed ID: 35387594 [TBL] [Abstract][Full Text] [Related]
3. High incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National antiretroviral therapy programme between 2011 and 2015. Mupfumi L; Moyo S; Shin SS; Wang Q; Zetola N; Molebatsi K; Nnawa J; Kgwaadira BT; Bewlay L; Chebani T; Iketleng T; Mogashoa T; Makhema J; Musonda RM; Essex M; Kasvosve I; Gaseitsiwe S AIDS; 2019 Dec; 33(15):2415-2422. PubMed ID: 31764106 [TBL] [Abstract][Full Text] [Related]
4. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa. Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873 [TBL] [Abstract][Full Text] [Related]
5. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study. Assefa A; Gelaw B; Getnet G; Yitayew G BMC Infect Dis; 2014 Aug; 14():468. PubMed ID: 25164855 [TBL] [Abstract][Full Text] [Related]
6. Role of CD4/CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade. Wolday D; Kebede Y; Legesse D; Siraj DS; McBride JA; Kirsch MJ; Striker R PLoS One; 2020; 15(5):e0233049. PubMed ID: 32442166 [TBL] [Abstract][Full Text] [Related]
7. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa. Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524 [TBL] [Abstract][Full Text] [Related]
8. Tuberculosis incidence in country of origin is a key determinant of the risk of active tuberculosis in people living with HIV: Data from a 30-year observational cohort study. White HA; Okhai H; Kirwan P; Rafeeq SH; Dillon H; Hefford P; Wiselka MJ; Pareek M HIV Med; 2022 Jul; 23(6):650-660. PubMed ID: 34939299 [TBL] [Abstract][Full Text] [Related]
9. Rapid antiretroviral initiation among Thai youth living with HIV in the National AIDS programme in the era of treatment at any CD4 cell count: a national registry database study. Teeraananchai S; Kerr SJ; Khananuraksa P; Ruxrungtham K; Puthanakit T J Int AIDS Soc; 2020 Sep; 23 Suppl 5(Suppl 5):e25574. PubMed ID: 32869537 [TBL] [Abstract][Full Text] [Related]
10. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi. Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836 [TBL] [Abstract][Full Text] [Related]
11. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India. Dravid A; Natarajan K; Medisetty M; Gawali R; Mahajan U; Kulkarni M; Saraf C; Ghanekar C; Kore S; Rathod N; Dravid M BMC Infect Dis; 2019 Aug; 19(1):714. PubMed ID: 31409289 [TBL] [Abstract][Full Text] [Related]
12. Implementation and Operational Research: Declining Tuberculosis Incidence Among People Receiving HIV Care and Treatment Services in East Africa, 2007-2012. Saito S; Mpofu P; Carter EJ; Diero L; Wools-Kaloustian KK; Yiannoutsos CT; Beverly MS; Tsiouris S; Somi GR; Ssali J; Nash D; Elul B J Acquir Immune Defic Syndr; 2016 Apr; 71(4):e96-e106. PubMed ID: 26910387 [TBL] [Abstract][Full Text] [Related]
13. Risk of tuberculosis after initiation of antiretroviral therapy among persons with HIV in Europe. Johansen IS; Roen A; Kraef C; Martín-Iguacel R; Nemeth J; Fenner L; Zangerle R; Llibre JM; Miller RF; Suarez I; de Wit S; Wit F; Mussini C; Saracino A; Canetti D; Volny-Anne A; Jaschinski N; Neesgaard B; Ryom L; Peters L; Garges HP; Rooney JF; Podlekareva D; Mocroft A; Kirk O; Int J Infect Dis; 2024 Oct; 147():107199. PubMed ID: 39142437 [TBL] [Abstract][Full Text] [Related]
14. Tuberculosis prevalence, incidence and prevention in a south african cohort of children living with HIV. Anyalechi GE; Bain R; Kindra G; Mogashoa M; Sogaula N; Mutiti A; Arpadi S; Rivadeneira E; Abrams EJ; Teasdale CA J Trop Pediatr; 2022 Oct; 68(6):. PubMed ID: 36269203 [TBL] [Abstract][Full Text] [Related]
15. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548 [TBL] [Abstract][Full Text] [Related]
16. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy. Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295 [TBL] [Abstract][Full Text] [Related]
17. Preventing tuberculosis with community-based care in an HIV-endemic setting: a modelling analysis. Ross JM; Greene C; Broshkevitch CJ; Dowdy DW; van Heerden A; Heitner J; Rao DW; Roberts DA; Shapiro AE; Zabinsky ZB; Barnabas RV J Int AIDS Soc; 2024 Jun; 27(6):e26272. PubMed ID: 38861426 [TBL] [Abstract][Full Text] [Related]
18. Incidence and mortality of tuberculosis before and after initiation of antiretroviral therapy: an HIV cohort study in India. Alvarez-Uria G; Pakam R; Midde M; Naik PK J Int AIDS Soc; 2014; 17(1):19251. PubMed ID: 25499123 [TBL] [Abstract][Full Text] [Related]
19. Tuberculosis incidence and mortality in people living with human immunodeficiency virus: a Danish nationwide cohort study. Martin-Iguacel R; Llibre JM; Pedersen C; Obel N; Stærke NB; Åhsberg J; Ørsted I; Holden I; Kronborg G; Mohey R; Rasmussen LD; Johansen IS Clin Microbiol Infect; 2022 Apr; 28(4):570-579. PubMed ID: 34438070 [TBL] [Abstract][Full Text] [Related]
20. Incidence of tuberculosis in HIV-infected adults on first- and second-line antiretroviral therapy in India. Gupte AN; Kadam D; Sangle S; Rewari BB; Salvi S; Chavan A; Nimkar S; Golub J; Gupte N; Gupta A; Marbaniang I; Mave V BMC Infect Dis; 2019 Oct; 19(1):914. PubMed ID: 31664933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]